![Joe Wiley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joe Wiley
Directeur Général chez
AMRYT PHARMA PLC
Profil
Joseph A. Wiley was the founder of Amryt Pharma Holdings Ltd., founded in 2015, where the title held was Chief Executive Officer & Executive Director from 2016 to 2023.
Dr. Wiley is the founder of Amryt Pharma PLC, founded in 2015, holding the title of Chief Executive Officer since 2015.
Current jobs include Chief Executive Officer at Amryt Pharmaceuticals DAC, Chairman & Chief Executive Officer at Gamida Cell Ltd., and Member at the Royal College of Physicians of Ireland.
Former jobs include Chief Executive Officer at Enlarged Group, President & Director at Aegerion Pharmaceuticals, Inc., Investment Director at Aberdeen Asset Managers Private Equity from 2005 to 2008, Investment Director at Synova LLP in 2010, Director-Medical at Astellas Pharma Co. Ltd. from 2010 to 2012, Investment Manager at Inventages Venture Capital Investment, Inc, Independent Member-Supervisory Board at Innocoll AG, Member-Supervisory Board at Innocoll Biotherapeutics Holdings Ltd., and Principal at Sofinnova Investments, Inc. Education includes an MBA degree from INSEAD.
Postes actifs de Joe Wiley
| Sociétés | Poste | Début |
|---|---|---|
| AMRYT PHARMA PLC | Directeur Général | 01/08/2015 |
| GAMIDA CELL LTD. | Directeur Général | - |
Amryt Pharmaceuticals DAC
 Amryt Pharmaceuticals DAC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Royal College of Physicians of Ireland
 Royal College of Physicians of Ireland Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Joe Wiley
| Sociétés | Poste | Fin |
|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Fondateur | 26/05/2023 |
Astellas Pharma Co. Ltd.
 Astellas Pharma Co. Ltd. Medical DistributorsDistribution Services Wholesales medical products | Directeur Technique/Scientifique/R&D | 01/04/2012 |
Synova Capital LLP
 Synova Capital LLP Investment ManagersFinance Synova Capital invests in lower mid-market companies located in the United Kingdom with an enterprise value of EUR 20 - 250 million. The firm targets companies operating in the fields of business services, financial services, consumer brands, healthcare & education and technology sectors. It provides financing for buy-ins, buy-outs and development capital transactions with an investment size of EUR 15 - 150 million. | Private Equity Investor | 01/08/2010 |
Aberdeen Asset Managers Private Equity
 Aberdeen Asset Managers Private Equity Investment ManagersFinance AAMPE is an active investor supported by the group's fundamental bottom-up research and process-driven approach. Their objective is to add value. They target UK mid-market investments ranging from GBP 10 million and GBP 50 million with a particular focus on support services, consumer and leisure, specialist manufacturing and financial services. They also have a particular interest in the environmental sector and in business services. AAMPE's key investment selection criteria within their targeted sectors are the prospective firms' management and business model and attractively priced opportunities. They eschew benchmarks and follow a team-based approach for all investment decisions. | Director of Investments | 31/08/2008 |
Inventages Venture Capital Investment, Inc
 Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 06/03/2006 |
Formation de Joe Wiley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Aberdeen Asset Managers Private Equity
Aberdeen Asset Managers Private Equity Investment ManagersFinance AAMPE is an active investor supported by the group's fundamental bottom-up research and process-driven approach. Their objective is to add value. They target UK mid-market investments ranging from GBP 10 million and GBP 50 million with a particular focus on support services, consumer and leisure, specialist manufacturing and financial services. They also have a particular interest in the environmental sector and in business services. AAMPE's key investment selection criteria within their targeted sectors are the prospective firms' management and business model and attractively priced opportunities. They eschew benchmarks and follow a team-based approach for all investment decisions. | Finance |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inventages Venture Capital Investment, Inc
Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture invests in companies located across the globe. The firm targets companies operating in the fields of diagnostics, drugs, OTC, medical and functional foods, nutraceuticals and enabling technologies. It provides financing for seed and early stage capital requirements. | Finance |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Synova Capital LLP
Synova Capital LLP Investment ManagersFinance Synova Capital invests in lower mid-market companies located in the United Kingdom with an enterprise value of EUR 20 - 250 million. The firm targets companies operating in the fields of business services, financial services, consumer brands, healthcare & education and technology sectors. It provides financing for buy-ins, buy-outs and development capital transactions with an investment size of EUR 15 - 150 million. | Finance |
Enlarged Group | |
Astellas Pharma Co. Ltd.
Astellas Pharma Co. Ltd. Medical DistributorsDistribution Services Wholesales medical products | Distribution Services |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Royal College of Physicians of Ireland
Royal College of Physicians of Ireland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
Amryt Pharmaceuticals DAC
Amryt Pharmaceuticals DAC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
Choisissez Zonebourse 
